Difference between revisions of "Dermagraft-TC"
Jump to navigation
Jump to search
m |
m |
||
| Line 7: | Line 7: | ||
| first= | | first= | ||
| publisher=Advanced Biohealing, Inc. | | publisher=Advanced Biohealing, Inc. | ||
| − | | | + | | website= |
| date= | | date= | ||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
| Line 17: | Line 17: | ||
| first= | | first= | ||
| publisher=MediLexicon | | publisher=MediLexicon | ||
| − | | | + | | website= |
| date= | | date= | ||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
| Line 30: | Line 30: | ||
| quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | | quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | ||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
| − | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref> | + | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal |
| + | | last=Daecher | ||
| + | | first=M. | ||
| + | | coauthors= | ||
| + | | title=Circumcision | ||
| + | | journal=Icon | ||
| + | | date=1998 | ||
| + | | volume=2 | ||
| + | | issue=2 | ||
| + | | pages=70-73 | ||
| + | | url= | ||
| + | | quote= | ||
| + | | pubmedID= | ||
| + | | pubmedCID= | ||
| + | | DOI= | ||
| + | | accessdate= | ||
| + | }}</ref> | ||
{{REF}} | {{REF}} | ||
Revision as of 18:02, 20 September 2019
Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
Dermagraft-TC
, MediLexicon. Retrieved 6 March 2011.
Quote:...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑
(28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
Quote:...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
- ↑
Daecher, M.. Circumcision. Icon. 1998; 2(2): 70-73.
